Our Company
Our Mission & Commitment
Key Facts
Leadership
Governance
History
Compliance & Ethics
Diversity & Inclusion
Our Websites
Achievements
Business Information
R&D
R&D Strategy
In the Pipeline
Investigational Compound News
Disease Areas of Focus
Our R&D
Our Science
R&D Highlights
Major R&D Facilities
Clinical Trials
Investigator- Sponsored Research
Products
Help Paying For Your Medicine
Counterfeit Drugs
Medical Information Inquiries
News
Press Releases
Publications
Media Library
Key Facts
Leadership
Financial Reporting
Features
Achievements
Media Contacts
Subscribe to e-mail alerts
Investors
Key Facts
Stock Information
SEC Filings
Financial Reporting
Events & Presentations
Shareholder Services
Investor Contacts
Partnering
Why Partner With Us?
Areas of Interest
Our Process
Our Partners
Partnering News
Partnering Contact
Responsibility
Bristol-Myers Squibb Foundation
Sustainability
Help Paying For Your Medicine
Building Our Communities
Grants & Giving
Position on Key Issues
Transparency
Clinical Trials
Combating Counterfeit Drugs
Disaster Relief & Product Donations
Achievements
Access to Medicines
Careers
Job Opportunities
Our Culture
Diversity & Inclusion
Developing Our People
University Recruitment
Achievements
Benefits
Apply Now
SITE INDEX
|
CONTACT US
|
TERMS
|
PRIVACY
Clinical Trials and Research
Learn about Bristol-Myers Squibb's
Clinical Trial Activities
and
Investigator-Sponsored Research
Need Help Paying for Your
Bristol-Myers Squibb Medicines?
Learn about our
assistance programs
.
Patients and
Caregivers
Learn about clinical trial participation at
Bristol-Myers Squibb
Study Connect
Health Care Professionals
Access
medical information and resources
California Transparency in Supply Chains (PDF)
Our Environmental Stewardship
Bristol-Myers Squibb Delivers Solid Fourth Quarter Results
Year highlighted by new product approvals, continued focus on strategic transactions and good operating performance
Combating Neglected Tropical Diseases
Company joins global initiative
LATEST NEWS
February 3, 2012
Bristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Inhibitex, Inc.
January 26, 2012
Bristol-Myers Squibb Delivers Solid Fourth Quarter Capping a Year Highlighted by New Product Approvals, Continued Execution of Strategic Transactions and Good Operating Performance
January 24, 2012
Bristol-Myers Squibb Names Gerald L. Storch to Board of Directors
January 19, 2012
Bristol-Myers Squibb Announces Charitable Donation of $6.9 Million to Support Cancer Patients
Get RSS News Alerts
Follow us on twitter.com/bmsnews